Psychometric properties comparison of EQ-5D-Y-3L and CHU-9D in children with adenoid hypertrophy.

IF 3.1 3区 医学 Q1 ECONOMICS
Xue Wan, Junyan Liang, Jiaxue Fan, Mingqi Peng, Jing Zhou, Hua You
{"title":"Psychometric properties comparison of EQ-5D-Y-3L and CHU-9D in children with adenoid hypertrophy.","authors":"Xue Wan, Junyan Liang, Jiaxue Fan, Mingqi Peng, Jing Zhou, Hua You","doi":"10.1007/s10198-026-01974-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to assess the psychometric properties of two preference-based instruments, EQ-5D-Y-3 L and CHU-9D, in assessing the health-related quality of life of children with adenoid hypertrophy.</p><p><strong>Methods: </strong>EQ-5D-Y-3 L and CHU-9D were completed in a random sequence by children with adenoid hypertrophy (aged 8-15years) from three hospitals in XX city. The instruments were systematically compared for distribution, ceiling effects, agreement, construct validity, known‑groups validity, and discriminative ability (via AUC, relative efficiency, orthogonal polynomial contrasts, and ANCOVA) in distinguishing disease severity levels.</p><p><strong>Results: </strong>This study compared the performance of the EQ-5D-Y-3 L and CHU-9D in 644 children with adenoid hypertrophy (mean age 10.63 years). The two instruments showed poor agreement (ICC = 0.691). In discriminating disease severity, the CHU-9D demonstrated superior sensitivity, with larger effect sizes (η²=0.257), and its relative efficiency suggested approximately 1.39 times greater overall discriminative ability (reference: EQ-5D-Y-3 L = 1). However, pairwise Cohen's d values were small for both instruments (range:0.108-0.163). ANCOVA confirmed these advantages persisted after adjusting for covariates.</p><p><strong>Conclusions: </strong>The EQ-5D-Y-3L and CHU-9D were not interchangeable in children with adenoid hypertrophy. The CHU-9D showed superior discriminatory sensitivity, larger global effect sizes, and better model fit, particularly in detecting mild to moderate disease changes. Therefore, in health economic evaluations, the CHU-9D may be more suitable when the study aim is to identify early-stage or subtle health changes. In contrast, the EQ-5D-Y-3L provides a more stable model for assessing a consistent linear relationship between disease severity and health utility. Researchers should select the instrument based on clearly defined study objectives, while acknowledging that the observed pairwise effect sizes were modest and warrant further validation.</p>","PeriodicalId":51416,"journal":{"name":"European Journal of Health Economics","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Health Economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10198-026-01974-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study aims to assess the psychometric properties of two preference-based instruments, EQ-5D-Y-3 L and CHU-9D, in assessing the health-related quality of life of children with adenoid hypertrophy.

Methods: EQ-5D-Y-3 L and CHU-9D were completed in a random sequence by children with adenoid hypertrophy (aged 8-15years) from three hospitals in XX city. The instruments were systematically compared for distribution, ceiling effects, agreement, construct validity, known‑groups validity, and discriminative ability (via AUC, relative efficiency, orthogonal polynomial contrasts, and ANCOVA) in distinguishing disease severity levels.

Results: This study compared the performance of the EQ-5D-Y-3 L and CHU-9D in 644 children with adenoid hypertrophy (mean age 10.63 years). The two instruments showed poor agreement (ICC = 0.691). In discriminating disease severity, the CHU-9D demonstrated superior sensitivity, with larger effect sizes (η²=0.257), and its relative efficiency suggested approximately 1.39 times greater overall discriminative ability (reference: EQ-5D-Y-3 L = 1). However, pairwise Cohen's d values were small for both instruments (range:0.108-0.163). ANCOVA confirmed these advantages persisted after adjusting for covariates.

Conclusions: The EQ-5D-Y-3L and CHU-9D were not interchangeable in children with adenoid hypertrophy. The CHU-9D showed superior discriminatory sensitivity, larger global effect sizes, and better model fit, particularly in detecting mild to moderate disease changes. Therefore, in health economic evaluations, the CHU-9D may be more suitable when the study aim is to identify early-stage or subtle health changes. In contrast, the EQ-5D-Y-3L provides a more stable model for assessing a consistent linear relationship between disease severity and health utility. Researchers should select the instrument based on clearly defined study objectives, while acknowledging that the observed pairwise effect sizes were modest and warrant further validation.

腺样体肥大患儿EQ-5D-Y-3L与CHU-9D的心理测量特性比较。
目的:本研究旨在评估两种基于偏好的工具eq - 5d - y - 3l和CHU-9D在评估腺样体肥大儿童健康相关生活质量中的心理测量特性。方法:对XX市3家医院8 ~ 15岁腺样体肥大患儿随机进行eq - 5d - y - 3l和CHU-9D检测。系统地比较了这些工具在区分疾病严重程度方面的分布、上限效应、一致性、结构效度、已知组效度和判别能力(通过AUC、相对效率、正交多项式对比和ANCOVA)。结果:本研究比较了eq - 5d - y - 3l和CHU-9D在644例腺样体肥大患儿(平均年龄10.63岁)中的表现。两种仪器的一致性较差(ICC = 0.691)。在区分疾病严重程度方面,CHU-9D表现出更高的灵敏度,具有更大的效应量(η²=0.257),其相对效率表明其总体区分能力约为1.39倍(参考文献:EQ-5D-Y-3 L = 1)。然而,两种工具的成对Cohen’s d值都很小(范围:0.108-0.163)。ANCOVA证实,在调整协变量后,这些优势仍然存在。结论:EQ-5D-Y-3L和CHU-9D在腺样体肥大患儿中不可互换。CHU-9D具有更好的区分敏感性、更大的整体效应量和更好的模型拟合,特别是在检测轻度至中度疾病变化方面。因此,在健康经济评价中,当研究目的是识别早期或细微的健康变化时,CHU-9D可能更适用。相比之下,EQ-5D-Y-3L为评估疾病严重程度与健康效用之间一致的线性关系提供了更稳定的模型。研究人员应根据明确定义的研究目标来选择工具,同时承认观察到的成对效应量是适度的,需要进一步验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
2.30%
发文量
131
期刊介绍: The European Journal of Health Economics is a journal of Health Economics and associated disciplines. The growing demand for health economics and the introduction of new guidelines in various European countries were the motivation to generate a highly scientific and at the same time practice oriented journal considering the requirements of various health care systems in Europe. The international scientific board of opinion leaders guarantees high-quality, peer-reviewed publications as well as articles for pragmatic approaches in the field of health economics. We intend to cover all aspects of health economics: • Basics of health economic approaches and methods • Pharmacoeconomics • Health Care Systems • Pricing and Reimbursement Systems • Quality-of-Life-Studies The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements. Officially cited as: Eur J Health Econ
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书